US court orders $834 mn from BMS, Sanofi on Plavix: reports
A Hawaii court ordered Bristol-Myers Squibb and Sanofi to pay the state $834 million over marketing claims for blood thinner, Plavix, according to news reports.
Feb 16, 2021
0
3
A Hawaii court ordered Bristol-Myers Squibb and Sanofi to pay the state $834 million over marketing claims for blood thinner, Plavix, according to news reports.
Feb 16, 2021
0
3
The pharmaceutical industry is targeting vulnerable Americans with predatory pricing that is forcing them to ration life-saving drugs, according to a three-year congressional probe released Friday.
Dec 10, 2021
0
13
Researchers at the University of Maryland School of Medicine have begun collecting broad health information from 250,000 volunteers around the state in an effort to uncover better ways of treating and preventing all kinds ...
Jul 28, 2022
0
3
Medicare often spends $3,590 for an individual's 30-day prescription after adjusting for all rebates, and prices continue to rise.
Sep 5, 2019
0
12
The Food and Drug Administration (FDA) recently announced plans to require tobacco companies to cut the amount of nicotine in traditional cigarettes. It also announced a ban of Juul e-cigarettes in the U.S., saying the company ...
Jul 20, 2022
0
44
Secrecy surrounding executions could hinder efforts by a group of medical professionals who are asking the nation's death penalty states for medications used in lethal injections so that they can go to coronavirus patients ...
Apr 21, 2020
0
4
New research led by the University of South Australia shows that a blanket approach to prescribing medication during pregnancy may put low birth weight babies at risk for the rest of their lives.
Sep 8, 2020
0
4
From HIV to Ebola, and now COVID-19, inequality in access to medicines and vaccines has been prevalent in developing countries for decades.
Mar 30, 2022
0
2
Over the past thirteen years, many Australian women have used the drug mifepristone (RU486) to bring about a medical abortion.
Apr 1, 2019
0
1
Pfizer Inc. announced Tuesday that it has asked the U.S. Food and Drug Administration to approve emergency use of its booster shot for children ages 5 to 11 years.
Apr 28, 2022
0
7